Treatment of SLE Patients with the Immunoproteasome Inhibitor KZR-616: Results from the First 3 Cohorts of an Open-Label Phase 1b Dose Escalation Trial

Conference Paper

Full Text

Link to Item

Duke Authors

Goel, Niti

Cited Authors

Furie, R; Bomba, D; Dall'Era, M; Khan, A; Soneira, M; Anderl, J; Wang, J; Kirk, C; Goel, N

Published Date

October 1, 2019

Published In

Arthritis & Rheumatology

Volume / Issue

71 /

Published By

WILEY

Pages

3

Electronic International Standard Serial Number (EISSN)

2326-5205

International Standard Serial Number (ISSN)

2326-5191